PL1800678T3 - Kombinacja inhibitora prądu If węzła zatokowego i inhibitora enzymu konwersji angiotensyny - Google Patents

Kombinacja inhibitora prądu If węzła zatokowego i inhibitora enzymu konwersji angiotensyny

Info

Publication number
PL1800678T3
PL1800678T3 PL06291993T PL06291993T PL1800678T3 PL 1800678 T3 PL1800678 T3 PL 1800678T3 PL 06291993 T PL06291993 T PL 06291993T PL 06291993 T PL06291993 T PL 06291993T PL 1800678 T3 PL1800678 T3 PL 1800678T3
Authority
PL
Poland
Prior art keywords
inhibitor
combination
current
sinus node
conversion enzyme
Prior art date
Application number
PL06291993T
Other languages
English (en)
Inventor
Vidal Benatar
Guy Lerebours-Pigeonniere
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36685870&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1800678(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of PL1800678T3 publication Critical patent/PL1800678T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
PL06291993T 2005-12-21 2006-12-20 Kombinacja inhibitora prądu If węzła zatokowego i inhibitora enzymu konwersji angiotensyny PL1800678T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0513006A FR2894825B1 (fr) 2005-12-21 2005-12-21 Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
EP06291993A EP1800678B1 (fr) 2005-12-21 2006-12-20 Association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine

Publications (1)

Publication Number Publication Date
PL1800678T3 true PL1800678T3 (pl) 2011-08-31

Family

ID=36685870

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06291993T PL1800678T3 (pl) 2005-12-21 2006-12-20 Kombinacja inhibitora prądu If węzła zatokowego i inhibitora enzymu konwersji angiotensyny

Country Status (42)

Country Link
US (2) US20070142355A1 (pl)
EP (2) EP2298297A1 (pl)
JP (2) JP4705564B2 (pl)
KR (2) KR100907583B1 (pl)
CN (1) CN101015557B (pl)
AP (1) AP2119A (pl)
AR (1) AR058574A1 (pl)
AT (1) ATE508742T1 (pl)
AU (1) AU2006252210B2 (pl)
BR (1) BRPI0605517A (pl)
CA (1) CA2571644C (pl)
CO (1) CO5790168A1 (pl)
CR (1) CR8820A (pl)
CY (1) CY1111575T1 (pl)
DK (1) DK1800678T3 (pl)
EA (1) EA011253B1 (pl)
ES (1) ES2366570T3 (pl)
FR (1) FR2894825B1 (pl)
GE (1) GEP20094604B (pl)
GT (1) GT200600522A (pl)
HR (1) HRP20110532T1 (pl)
IL (1) IL180204A (pl)
JO (1) JO2699B1 (pl)
MA (1) MA28723B1 (pl)
ME (1) ME01958B (pl)
MX (1) MXPA06014885A (pl)
MY (1) MY146956A (pl)
NO (1) NO337640B1 (pl)
NZ (1) NZ552221A (pl)
PE (2) PE20110116A1 (pl)
PL (1) PL1800678T3 (pl)
PT (1) PT1800678E (pl)
PY (1) PY0639426A (pl)
RS (1) RS51731B (pl)
SA (1) SA06270480B1 (pl)
SG (2) SG133545A1 (pl)
SI (1) SI1800678T1 (pl)
TW (1) TWI369206B (pl)
UA (1) UA86417C2 (pl)
UY (1) UY30023A1 (pl)
WO (1) WO2007077327A1 (pl)
ZA (1) ZA200610824B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
FR2920772B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine
FR2927538B1 (fr) * 2008-02-14 2010-02-19 Servier Lab Association d'un inhibiteur du courant if sinusal et d'un beta-bloquant.
CN101564394B (zh) * 2008-04-21 2010-12-15 鲁南制药集团股份有限公司 含有伊伐布雷定和曲美他嗪的药物组合物
FR2961105B1 (fr) 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
WO2013116738A1 (en) * 2012-02-03 2013-08-08 Cardeus Pharmaceuticals, Inc. Drug formulations
PH12018502155B1 (en) 2016-04-20 2024-03-27 Servier Lab Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508729A (en) * 1979-12-07 1985-04-02 Adir Substituted iminodiacids, their preparation and pharmaceutical compositions containing them
DE3736866A1 (de) * 1987-10-30 1989-05-11 Thomae Gmbh Dr K Mittel zur behandlung des bluthochdrucks und der herzinsuffizienz
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
DE10018401A1 (de) * 2000-04-13 2001-10-25 Boehringer Ingelheim Pharma Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
CA2450027A1 (en) * 2001-06-08 2002-12-19 Ortho-Mcneil Pharmaceutical, Inc. Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
AR036187A1 (es) * 2001-07-24 2004-08-18 Adir Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario
WO2003024457A1 (en) * 2001-09-11 2003-03-27 Asahi Kasei Kabushiki Kaisha Medicinal composition for prevention of or treatment for cerebrovascular disorder and cardiopathy
FR2834896B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'ivabradine
FR2838648B1 (fr) * 2002-04-18 2004-05-21 Servier Lab Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
ES2211846T3 (es) * 2002-07-25 2004-07-16 BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG Uso de cilobradina o sus sales farmaceuticamente aceptables para el tratamiento o la prevencion de la insuficiencia cardiaca.
FR2882554B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme critalline beta d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882553B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882556B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882555B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
EP1800678A1 (fr) 2007-06-27
MXPA06014885A (es) 2009-02-11
CA2571644A1 (fr) 2007-06-21
CO5790168A1 (es) 2007-08-31
DK1800678T3 (da) 2011-08-15
KR20070066921A (ko) 2007-06-27
EP2298297A1 (fr) 2011-03-23
TWI369206B (en) 2012-08-01
US20070142355A1 (en) 2007-06-21
ZA200610824B (en) 2008-06-25
US20120196850A1 (en) 2012-08-02
MA28723B1 (fr) 2007-07-02
UY30023A1 (es) 2007-01-31
SA06270480B1 (ar) 2011-02-23
FR2894825A1 (fr) 2007-06-22
GT200600522A (es) 2007-07-25
JO2699B1 (en) 2013-03-03
ME01958B (me) 2011-10-31
KR20090047424A (ko) 2009-05-12
EP1800678B1 (fr) 2011-05-11
AR058574A1 (es) 2008-02-13
HK1106444A1 (en) 2008-03-14
NO337640B1 (no) 2016-05-23
AU2006252210B2 (en) 2012-04-26
GEP20094604B (en) 2009-02-10
NO20065905L (no) 2007-06-22
BRPI0605517A (pt) 2007-10-16
AU2006252210A1 (en) 2007-07-05
JP4705564B2 (ja) 2011-06-22
SI1800678T1 (sl) 2011-08-31
CA2571644C (fr) 2011-03-08
CY1111575T1 (el) 2015-10-07
WO2007077327A1 (fr) 2007-07-12
IL180204A (en) 2014-02-27
ATE508742T1 (de) 2011-05-15
AP2006003859A0 (en) 2006-12-31
EA200602155A1 (ru) 2007-08-31
PE20071004A1 (es) 2007-11-17
HRP20110532T1 (hr) 2011-08-31
SG173243A1 (en) 2011-08-29
UA86417C2 (ru) 2009-04-27
JP2007169283A (ja) 2007-07-05
JP2011079854A (ja) 2011-04-21
PY0639426A (es) 2011-10-03
KR100907583B1 (ko) 2009-07-14
IL180204A0 (en) 2008-01-20
RS51731B (sr) 2011-10-31
NZ552221A (en) 2008-05-30
ES2366570T3 (es) 2011-10-21
MY146956A (en) 2012-10-15
AP2119A (en) 2010-04-21
SG133545A1 (en) 2007-07-30
FR2894825B1 (fr) 2010-12-03
TW200744608A (en) 2007-12-16
PT1800678E (pt) 2011-07-12
PE20110116A1 (es) 2011-03-02
CN101015557A (zh) 2007-08-15
EA011253B1 (ru) 2009-02-27
CR8820A (es) 2007-08-28
CN101015557B (zh) 2010-12-08

Similar Documents

Publication Publication Date Title
DK1654360T3 (da) Amplificering fremgangsmåde
IS8370A (is) Virk sílíköt hliðarmálma
DE602005023864D1 (de) Strommodus-instrumentationsverstärker
FI20040285L (fi) Hajautettu dynaaminen reititys
NO20034955D0 (no) Korrosjonsinhibitor
DK1957149T3 (da) Komprimerbare elektroder
DE602007008345D1 (de) Gleichstromwandler und -Spannungsverstärker
EP1896951A4 (en) Managing memory pages
DE602006021150D1 (de) Monolithisch integrierte leistungsverstärkereinrichtung
DE602005009081D1 (de) Dynamische Speicherkonfigurierung
DE602005001217D1 (de) Dynamische Entzerrung
SI1800678T1 (sl) Kombinacija zaviralca lf toka sinusnega vozla in zaviralca angiotenzin-konvertaze
FI20055682L (fi) Läpivientiosa sekä menetelmä
EP1910272A4 (en) Renin Inhibitors
DE10391977D2 (de) Batterieanordnung
DE502005008898D1 (de) Spannungskomparator
FR2920772B1 (fr) Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine
ITPD20040270A1 (it) Struttura perfezionata di muffola
EP1704861A4 (en) lipase
BRPI0313614A2 (pt) separador dinâmico
FR2843451B1 (fr) Fronde du type lance-pierres
EP1931370A4 (en) USE OF DES-ASPARTATE-ANGIOTENSIN I
DE502004007610D1 (de) Analysierung des Lastverhaltens einer Ausgangsschaltung
SE0402711L (sv) Reducering av effektuttag
FI20045146A0 (fi) Audioaktiivisuuden ilmaisu